Fmoc-L-cysteine is a protected, naturally occurring amino acid derivative in which L-cysteine bears an N-(9H-fluoren-9-ylmethoxycarbonyl) (Fmoc) group on the α-amino functionality and retains the free carboxylic acid as well as the thiol-containing cysteine side chain. The molecule features a stereogenic center consistent with the L-configuration indicated in the name, and its cysteine side chain provides a reactive sulfhydryl that can participate in disulfide formation or be controlled during synthesis depending on the reaction conditions. Fmoc-L-cysteine is used as a building block for stepwise peptide synthesis, where the Fmoc group enables chemoselective protection of the amino terminus while the cysteine side-chain functionality supports incorporation of thiol-bearing residues for subsequent derivatization, conjugation, or disulfide-related studies.
CAT No: CP00627
Fmoc-L-cysteine is an Fmoc-protected L-cysteine amino acid derivative that contains a chiral alpha carbon, a carboxylic acid functionality masked as the free acid (or typically handled as the amino acid for coupling), and a thioether-bearing side chain that can be converted into reactive thiol or further functionalized sulfur motifs. The molecule combines an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group on the amino terminus with the stereochemically defined L-configuration, enabling controlled peptide assembly while preserving side-chain integrity during standard coupling steps. The thioether sulfur participates in nucleophilic chemistry after thiol generation or activation, supporting downstream derivatization for disulfide formation, thioether exchange, or attachment of sulfur-containing handles. The presence of the aromatic Fmoc group and the amino acid backbone makes Fmoc-L-cysteine a practical chiral building block for both research-grade peptide synthesis and industrial intermediate preparation where protected amino acids are required.
1. Peptide Synthesis
Fmoc-L-cysteine is used in solid-phase peptide synthesis and related peptide building workflows where the Fmoc-protected amino group supports iterative N-terminal deprotection and coupling. The defined L-stereochemistry at the alpha carbon and the sulfur-containing side chain enable incorporation of cysteine residues into peptides while maintaining side-chain compatibility through orthogonal protection and controlled deprotection strategies. The thioether functionality can be carried through coupling steps and then converted to thiol equivalents for disulfide bond construction or for selective side-chain modifications, depending on the chosen protection scheme. The resulting cysteine-containing peptide products serve as substrates for peptide science studies, folding investigations, and scaffold generation in synthetic organic chemistry.
2. Side-Chain Functionalization
Fmoc-L-cysteine is applied in amino acid derivatization and chemical biology reagent preparation where the sulfur functionality serves as a handle for thiol-based conjugation chemistry. The Fmoc group provides an N-protection strategy that can be removed when needed, while the cysteine side chain can be transformed into reactive thiol forms or activated sulfur derivatives for subsequent coupling to electrophiles. Side-chain functionalization can be directed toward disulfide formation, thioether conjugation, or installation of linkers for affinity probes and labeling reagents. Downstream products include functionalized cysteine analogs and peptide conjugates used to probe molecular interactions, map binding sites, or generate tagged biomolecular constructs.
3. Protected Amino Acids
Fmoc-L-cysteine is suitable for protected amino acid synthesis workflows that require a stable, chiral N-protected cysteine building block compatible with peptide coupling chemistries. The Fmoc carbamate protecting group on the amine and the stereochemically defined L-configuration facilitate predictable handling during synthesis planning, including orthogonal deprotection sequences that separate backbone assembly from side-chain chemistry. The sulfur-containing side chain enables selection of downstream transformations after the peptide or intermediate framework is assembled, supporting controlled access to thiol-reactive intermediates. The compound therefore functions as a practical chiral starting material for fine chemical synthesis and for manufacturing routes that rely on protected amino acids as standardized inputs.
4. Bioconjugation Chemistry
Fmoc-L-cysteine is utilized in bioconjugation and chemical biology programs where cysteine residues provide a chemoselective entry point for attaching biomolecules to labels, polymers, or affinity tags. The amino acid backbone and Fmoc protection support preparation of peptide fragments or linkers that can be assembled into defined conjugation architectures before thiol-generation or activation. The sulfur functionality can participate in disulfide exchange or thiol-reactive coupling, enabling controlled installation of functional groups on proteins, peptides, or nucleic-acid conjugates under conditions compatible with peptide-derived materials. The resulting conjugates support analytical research, molecular recognition studies, and the generation of functional biomolecule derivatives for applied biochemical workflows.
5. Pharmaceutical Manufacturing
Fmoc-L-cysteine is relevant to pharmaceutical intermediate preparation and process chemistry where protected amino acid building blocks are incorporated into peptide-like or sulfur-functionalized intermediates during route development. The Fmoc-protected amine supports stepwise synthesis logic that aligns with manufacturing needs for reproducible protection/deprotection handling and predictable coupling behavior in controlled process environments. The cysteine side chain provides a sulfur functionality that can be carried into downstream steps for disulfide patterning, thioether formation, or installation of sulfur-containing moieties used in drug substance or drug product intermediate families. The compound can be employed as a chiral input for specialty chemical production where amino acid derivative quality and stereochemical integrity are required for consistent downstream transformations.
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.